Contraindications:
· K+: > 5.0 meq/dl
· Creatinine: >2.5mg/dl in Men,
or >2.0mg/dl in women
Monitoring of Eplerenone and Spironolactone
Drug
|
Monitored item
|
When, Frequency
|
Eplerenone
|
K+
|
Baseline, 1 week or 4
weeks, then periodically
|
Spironolactone
|
K+, Cr
|
1 week, q4 weeks x 3 months,
q3 months x 1 year, then q6 months
|
